Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 08 crawled time : 01:00 save search
GRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -1.79%
H: 2.7%
C: 2.59%
study
Adverum Biotechnologies to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
ADVM | News | $10.19 -7.36% -7.95% 310K
|
Health Technology
|
| O: -1.82%
H: 7.41%
C: 4.63%
global conference
AMGEN ANNOUNCES WEBCAST OF 2022 MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -0.38%
H: 2.27%
C: 2.21%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: 0.27%
global conference
Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: -6.24%
conference
Dynavax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -1.17%
H: 3.64%
C: 3.0%
global conference
Akero Therapeutics to Present Results from Phase 2b HARMONY Trial Investigating Efruxifermin in Patients with Pre-Cirrhotic NASHInvestor webcast on Tuesday, September 13 at 8:00 a.m. ET to present clinical data
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: -1.51%
H: 13.23%
C: 12.46%
trial therapeutics results efruxifermin phase 2b
Innovent's Sintilimab plus Chemotherapy Demonstrated PFS Benefit in Patients with EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Second Interim Analysis Results of the ORIENT-31 Study
Published: 2022-09-08 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.11%
H: 1.21%
C: 1.14%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
rient-31 lung plus results cancer study
EXER URGENT CARE OPENS 28TH LOCATION IN SOUTHERN CALIFORNIA EXPANDING TO SERVE THE SANTA MONICA COMMUNITY
Published: 2022-09-08 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 2.54%
H: 1.88%
C: 1.88%
care california
Golden Gate Global Project Brooklyn Basin Phase 2 is Now Available for Investment
Published: 2022-09-08 (Crawled : 01:00) - prnewswire.com
LEN | $154.12 -1.02% 0.0% 1.5M
|
Consumer Durables
|
| O: -1.01%
H: 1.79%
C: 1.69%
global phase 2
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.